AltMountain

Ishara Biotech Fund LP

Los Angeles, CA · CIK 2052609 · Managed by Ishara Investments LP
Emerging

Ishara Biotech Fund LP is a hedge fund based in Los Angeles, California. According to its most recent Form D, filed Jan 20, 2026, the fund has sold $8,491,000 of interests to 11 investors since its first sale in Jan 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Shaun Mehra; Ishara Partners GP, LLC; Ishara Investments LP.

Performance

No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$8,491,000Cumulative sales reported on Form D
Investors
11
First sale
Jan 2, 2025
Minimum investment
None set
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Shaun Mehra; Ishara Partners GP, LLC; Ishara Investments LP
Latest Form D
Jan 20, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Jan 20, 2026Form D/A (amendment)$8,491,00011SEC.gov ↗
Jan 17, 2025Form D$7,925,00010SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jan 17, 2025. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Ishara Biotech Fund LP

What is the minimum investment for Ishara Biotech Fund LP?

Ishara Biotech Fund LP's latest Form D, filed Jan 20, 2026, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Ishara Biotech Fund LP?

Ishara Biotech Fund LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has Ishara Biotech Fund LP raised?

Ishara Biotech Fund LP reports $8,491,000 sold from 11 investors on its Form D filed Jan 20, 2026. This is cumulative sales since the offering began, not current assets or performance.

Where is Ishara Biotech Fund LP based?

Ishara Biotech Fund LP is based in Los Angeles, California and is managed by Ishara Investments LP.

When did Ishara Biotech Fund LP launch?

Ishara Biotech Fund LP reports its first sale in Jan 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).

Size compared with every hedge fund

Raised more than 33% of the 1,049 hedge funds based in California, and more than 19% of all 10,139 that report sales.

More hedge funds in Los Angeles

Similar-size hedge funds in California

All hedge funds in California · Emerging managers